HSP60 as a Target of Anti-Ergotypic Regulatory T Cells
Author Information
Author(s): Quintana Francisco J., Mimran Avishai, Carmi Pnina, Mor Felix, Cohen Irun R.
Primary Institution: The Weizmann Institute of Science
Hypothesis
Can HSP60 function as an ergotope to regulate T-cell responses?
Conclusion
HSP60 can control both effector T cells and the regulatory T cells that target them.
Supporting Evidence
- HSP60 is presented by activated T cells to regulatory T cells.
- Anti-ergotypic T cells can inhibit pro-inflammatory responses.
- Vaccination with HSP60 reduces symptoms of adjuvant arthritis in rats.
- Activated T cells express HSP60, which can be recognized by regulatory T cells.
Takeaway
HSP60 helps the immune system by telling certain T cells to calm down when they are too active, which can help with diseases like arthritis.
Methodology
The study involved DNA vaccination with HSP60 and its fragments in rats, followed by analysis of T-cell responses and cytokine production.
Limitations
The study primarily used animal models, which may not fully translate to human responses.
Participant Demographics
Female Lewis rats, 1-2 months old.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website